NRCME Hypertension Guidelines 4 — Questions and Answers
Question 1: A CME is evaluating a driver who reports headache and visual disturbances with a BP of 190/120 mmHg during the exam. The appropriate action is:
- Refer immediately for emergency evaluation and do not certify (Correct answer)
- Certify for 30 days and recheck
- Recommend over-the-counter pain relievers and recheck in one week
- Certify for 3 months with close monitoring
Correct answer: Refer immediately for emergency evaluation and do not certify
A BP of 190/120 with symptoms such as headache and visual disturbances suggests a hypertensive urgency or emergency requiring immediate medical evaluation before any certification can be considered.
Question 2: After a driver's Stage 3 hypertension is treated and BP falls to 140/88 mmHg, the FMCSA guideline allows:
- Certification for up to 1 year with annual recertification (Correct answer)
- Immediate 2-year certification
- Permanent disqualification regardless of treatment
- Certification for 3 months only
Correct answer: Certification for up to 1 year with annual recertification
Once Stage 3 hypertension is treated and BP is controlled below 180/110, the driver may be certified, typically for no more than one year to ensure continued control.
Question 3: Which of the following best describes the FMCSA's position on antihypertensive medications and commercial driving?
- Drivers on antihypertensive medications may be certified if BP is controlled and side effects do not impair safe driving (Correct answer)
- All antihypertensive medications automatically disqualify a driver
- Only drivers on a single medication may be certified
- Medications are irrelevant; only the BP reading matters
Correct answer: Drivers on antihypertensive medications may be certified if BP is controlled and side effects do not impair safe driving
FMCSA allows drivers on antihypertensive medications to be certified provided their blood pressure is well-controlled and the medication's side effects do not compromise driving safety.
Question 4: A driver being treated for hypertension takes clonidine. Which side effect should the CME specifically ask about?
- Sedation and drowsiness (Correct answer)
- Peripheral neuropathy
- Hearing loss
- Blurred near vision
Correct answer: Sedation and drowsiness
Clonidine, a central alpha-2 agonist, commonly causes sedation and drowsiness, which can significantly impair a driver's alertness and reaction time.
Question 5: What is the primary reason the FMCSA requires separate BP thresholds for certification rather than a single cutoff?
- To stratify cardiovascular risk and tailor monitoring intervals to disease severity (Correct answer)
- To simplify the certification process for examiners
- To allow all hypertensive drivers to continue working without restriction
- To align with European driver certification standards
Correct answer: To stratify cardiovascular risk and tailor monitoring intervals to disease severity
The staged threshold system allows the CME to risk-stratify drivers — those with more severe hypertension are certified for shorter periods or disqualified to protect public safety.
Question 6: A driver on an ARB (angiotensin receptor blocker) for hypertension asks if there are driving-relevant risks. The CME should counsel about:
- Possible dizziness from hypotension, especially early in treatment (Correct answer)
- Increased alertness making night driving safer
- No relevant side effects for driving
- Mandatory disqualification while on ARBs
Correct answer: Possible dizziness from hypotension, especially early in treatment
ARBs can cause blood pressure to drop, particularly early in therapy or with dehydration, leading to dizziness or lightheadedness that could impair safe driving.
Question 7: A CME measures a driver's blood pressure as 142/91 mmHg. Per FMCSA guidelines, this falls into which stage and what is the maximum certification period?
- Stage 1 — up to 12 months (Correct answer)
- Normal — up to 24 months
- Stage 2 — up to 6 months
- Stage 3 — disqualified
Correct answer: Stage 1 — up to 12 months
A BP of 140-159/90-99 mmHg is Stage 1 hypertension under FMCSA guidelines, permitting certification for up to one year with annual follow-up.
NRCME Hypertension Guidelines 4
A CME is evaluating a driver who reports headache and visual disturbances with a BP of 190/120 mmHg during the exam.
The appropriate action is: